- Home
- CNTX vs STHO Comparison
CNTX vs STHO Comparison
Compare CNTX & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- STHO
- Stock Information
- Founded
- CNTX 2015
- STHO N/A
- Country
- CNTX United States
- STHO United States
- Employees
- CNTX 9
- STHO N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- STHO Real Estate
- Sector
- CNTX Health Care
- STHO Real Estate
- Exchange
- CNTX Nasdaq
- STHO Nasdaq
- Market Cap
- CNTX 78.0M
- STHO 89.7M
- IPO Year
- CNTX 2021
- STHO N/A
- Fundamental
- Price
- CNTX $0.78
- STHO $6.53
- Analyst Decision
- CNTX Strong Buy
- STHO
- Analyst Count
- CNTX 6
- STHO 0
- Target Price
- CNTX $6.50
- STHO N/A
- AVG Volume (30 Days)
- CNTX 94.4K
- STHO 93.2K
- Earning Date
- CNTX 05-07-2025
- STHO 05-20-2025
- Dividend Yield
- CNTX N/A
- STHO N/A
- EPS Growth
- CNTX N/A
- STHO N/A
- EPS
- CNTX N/A
- STHO N/A
- Revenue
- CNTX N/A
- STHO $113,297,000.00
- Revenue This Year
- CNTX N/A
- STHO N/A
- Revenue Next Year
- CNTX N/A
- STHO N/A
- P/E Ratio
- CNTX N/A
- STHO N/A
- Revenue Growth
- CNTX N/A
- STHO N/A
- 52 Week Low
- CNTX $0.55
- STHO $6.09
- 52 Week High
- CNTX $2.75
- STHO $14.50
- Technical
- Relative Strength Index (RSI)
- CNTX 45.08
- STHO 42.45
- Support Level
- CNTX $0.74
- STHO $6.11
- Resistance Level
- CNTX $0.85
- STHO $7.02
- Average True Range (ATR)
- CNTX 0.09
- STHO 0.35
- MACD
- CNTX -0.02
- STHO 0.06
- Stochastic Oscillator
- CNTX 13.67
- STHO 46.41
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.